Abrexa Pharmaceuticals, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 17
Rang # Quantité totale PI 88 266
Note d'activité PI 2/5.0    15
Rang # Activité PI 57 136

Brevets

Marques

8 0
4 0
5 0
0
 
Dernier brevet 2024 - Compounds for use in organ prese...
Premier brevet 2019 - 2,2,2-trifluoroacetic acid 1-(2,...

Derniers inventions, produits et services

2024 Invention Compounds for use in organ preservation and organ transplantation. Presented herein, in certain a...
Invention Compositions and methods for prevention and treatment of coronavirus and related disorders. Pres...
2022 Invention Compositions and methods for prevention and treatment of coronavirus and related disorders. Prese...
2021 Invention Compounds for prevention and treatment of hemorrhage and vasculature instability. Hemorrhage and...
Invention Compounds for prevention and treatment of hemorrhage and vasculature instability. Hemorrhage and ...
Invention Compounds for prevention and treatment of post-intensive care cognitive dysfunction and cognitive...
Invention 2,2,2-trifluoroacetic acid 1-(2,4-dimethylphenyl)-2-[(3-methoxyphenyl)methylene] method of making...
2020 Invention Compounds for prevention and treatment of post-operative cognitive dysfunction. Presented herein...
Invention Compounds for prevention and treatment of obesity and related disorders. Presented herein, in ce...
Invention Compounds for prevention and treatment of post-operative cognitive dysfunction. Presented herein,...
Invention Compounds for prevention and treatment of obesity and related disorders. Presented herein, in cer...
2019 Invention 2,2,2-trifluoroacetic acid 1-(2,4-dimethylphenyl)-2-[(3-methoxyphenyl)methylene] hydrazide polymo...